PNC-27 vs Collagen Peptides
Side-by-side comparison of key properties, dosing, and research.
Immune Support
PNC-27Skin & CosmeticRecovery & Repair
Collagen Peptides- Summary
- PNC-27 is a synthetic peptide derived from the p53 tumor suppressor protein, containing both an HDM2-binding domain and a transmembrane penetratin sequence. It selectively kills cancer cells by binding MDM2/HDM2 overexpressed on the plasma membrane of malignant cells, inducing membranolysis without harming normal cells.
- Collagen peptides are short-chain amino acid sequences produced by enzymatic hydrolysis of whole collagen (typically bovine or marine). They serve as bioactive signals that stimulate fibroblasts and chondrocytes to produce new collagen, elastin, and cartilage matrix, supporting skin, joint, bone, and gut health.
- Half-Life
- Not well established; estimated minutes to hours
- N/A — food-derived; absorbed peptides circulate for hours, depot accumulation in tissues
- Admin Route
- Intravenous (research), Intraperitoneal (research)
- Oral
- Research
- —
- —
- Typical Dose
- Not established for humans; research doses vary by cell line and model
- 10–15 g
- Frequency
- Not established for human use
- Once daily
- Key Benefits
- Selective cytotoxicity against cancer cells overexpressing HDM2/MDM2
- Spares normal cells lacking surface HDM2 expression
- Membranolytic mechanism bypasses intracellular resistance pathways
- Demonstrated activity against breast, pancreatic, leukemia, and melanoma cell lines
- Potential for combination with conventional chemotherapy
- Novel non-genotoxic anticancer mechanism
- Stimulates skin collagen and elastin production
- Reduces wrinkle depth and improves skin hydration
- Supports joint cartilage regeneration
- Reduces joint pain in osteoarthritis
- Promotes bone density (stimulates osteoblasts)
- Improves gut barrier integrity (leaky gut)
- Supports hair and nail growth
- Excellent amino acid profile for muscle recovery
- Side Effects
- Limited human clinical data; largely in vitro and animal studies
- Potential immunogenic reactions (foreign peptide)
- Systemic toxicity at high doses not well characterized
- Unknown interactions with current chemotherapy agents
- Excellent safety profile as food-derived protein
- Rare: bloating or GI discomfort at high doses
- Rare: allergic reaction (bovine or fish allergy)
- Mild bad taste (some forms)
- Stacks With
- —
- —